Interleukin-6 signaling drives fibrosis in unresolved inflammation.
Interleukin-6 signaling drives fibrosis in unresolved inflammation.
复制标题
DOI:
10.1016/j.immuni.2013.10.022
复制
发表时间:
2014-01-16
期刊:
影响因子:
32.4
通讯作者:
Jones, Simon A.
中科院分区:
文献类型:
--
作者:
Fielding, Ceri A.;Jones, Gareth W.;McLoughlin, Rachel M.;McLeod, Louise;Hammond, Victoria J.;Uceda, Javier;Williams, Anwen S.;Lambie, Mark;Foster, Thomas L.;Liao, Chia-Te;Rice, Christopher M.;Greenhill, Claire J.;Colmont, Chantal S.;Hams, Emily;Coles, Barbara;Kift-Morgan, Ann;Newton, Zarabeth;Craig, Katherine J.;Williams, John D.;Williams, Geraint T.;Davies, Simon J.;Humphreys, Ian R.;O'Donnell, Valerie B.;Taylor, Philip R.;Jenkins, Brendan J.;Topley, Nicholas;Jones, Simon A.
Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon-γ (IFN-γ), STAT1, or RAG-1. Here, IFN-γ and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic profibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation. Repeated acute resolving inflammation leads to excessive tissue damage IL-6 regulates profibrotic IFN-γ-secreting T cells IFN-γ increases detrimental STAT1 signaling in stromal tissue STAT1 activity alters homeostatic control of extracellular matrix to promote fibrosis
登录
查看更多内容
DOI:
10.1084/jem.20030077
发表时间:
2003-11-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Kano A;Wolfgang MJ;Gao Q;Jacoby J;Chai GX;Hansen W;Iwamoto Y;Pober JS;Flavell RA;Fu XY
通讯作者:
Fu XY
影响因子:
4.4
作者:
Ho, Hao H.;Antoniv, Taras T.;Ji, Jong-Dae;Ivashkiv, Lionel B.
通讯作者:
Ivashkiv, Lionel B.
影响因子:
29.4
作者:
Judd, Louise M.;Bredin, Karin;Giraud, Andrew S.
通讯作者:
Giraud, Andrew S.
影响因子:
4.4
作者:
Jones, Gareth W.;McLoughlin, Rachel M.;Jones, Simon A.
通讯作者:
Jones, Simon A.
影响因子:
64.8
作者:
HIRANO, T;YASUKAWA, K;KISHIMOTO, T
通讯作者:
KISHIMOTO, T